Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria

Milligan, Rachael, Daher, André and Graves, Patricia M (2017) 'Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria'. Cochrane Database of Systematic Reviews, CD012656.

Preview

Text Cochrane_Primaquine. Milligan_et_al-2017-.pdf - Published Version Available under License Creative Commons Attribution. Download (209kB) | Preview

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To assess the efficacy and safety of alternative primaquine regimens for radical cure ofP. vivax malaria compared to the standard 14 days of primaquine 0.25 mg/kg/day.

Item Type:	Article
Subjects:	QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 258 Primaquine. Quinacrine QX Parasitology > Protozoa > QX 135 Plasmodia WA Public Health > WA 30 Socioeconomic factors in public health (General) WA Public Health > Health Problems of Special Population Groups > WA 310 Maternal welfare WC Communicable Diseases > Tropical and Parasitic Diseases > WC 750 Malaria
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1002/14651858.cd012656
SWORD Depositor:	JISC Pubrouter
Depositing User:	Stacy Murtagh
Date Deposited:	04 Jan 2018 12:52
Last Modified:	22 Nov 2018 10:08
URI:	https://archive.lstmed.ac.uk/id/eprint/8031

Statistics

View details

Actions (login required)

Edit Item